Answer
Nasopharyngitis is a very common adverse reaction with Zeposia (ozanimod hydrochloride), reported in 12.3% of patients; very common means at least 1 in 10.
Sources for this answer
- Zeposia 0.23 mg, 0.46 and 0.92 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.8 Undesirable effects · Version 10Document updated
Sources checked